Integral Health Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-30,000
Closed -$5.56M 95
2025
Q3
$5.56M Buy
+30,000
New +$5.14M 0.38% 69
2023
Q3
Sell
-72,000
Closed -$11.9M 80
2023
Q2
$11.9M Buy
+72,000
New +$11.6M 1.48% 27
2021
Q1
Sell
-35,000
Closed -$5.51M 81
2020
Q4
$5.51M Buy
+35,000
New +$5.16M 1.64% 26

Other funds holding JNJ

Integral Health Asset Management's JNJ Position: Q4 2025 in Review

Integral Health Asset Management sold out of Johnson & Johnson (JNJ) in Q4 2025, closing a stake of 30,000 shares — an estimated $5.56M sold.

Integral Health Asset Management first reported a position in JNJ in Q4 2020 and held it in 3 quarters. The position peaked at $11.9M in Q2 2023. 4,520 funds tracked by Wall St. Rank hold JNJ as of Q4 2025.

  • Integral Health Asset Management reported no remaining Johnson & Johnson position as of Q4 2025 after selling out during the quarter.
  • Integral Health Asset Management sold 30,000 Johnson & Johnson shares in Q4 2025, an estimated $5.56M.
  • Integral Health Asset Management first reported a position in Johnson & Johnson in Q4 2020 and held it in 3 quarters.
  • Integral Health Asset Management's Johnson & Johnson position peaked at $11.9M in Q2 2023.
  • 4,520 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2025.

Based on Integral Health Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.